Increasing Demand For Medical Affairs Outsourcing Market

Published Date : 28 Mar 2023

The medical affairs outsourcing market size will be around USD 4.28 by 2030 from accounted for USD 1.70 in 2022 and is poised to grow at a CAGR of 12.2% between 2023 and 2032.

The medical affairs outsourcing market growth is driven by the stringent regulatory policies, cost-effective solutions and high-quality services provided by contract research organizations, and the increasing number of clinical trials on the account of the increasing prevalence rate of rare diseases.

Market Overview:

Medical affairs are the division within a medical device or pharmaceutical company responsible for communicating appropriate information to healthcare providers. Healthcare providers (HCPs), patients, and governmental organizations can gain in-depth knowledge of patient data as well as healthcare policies and practices by employing a technique referred to as medical affairs outsourcing.

The discovery and development of new medications need both money and time. From early discovery or design to development and regulatory approval, the process might take more than 10 to 15 years to complete. Many testing services are needed to ensure the quality and effectiveness of a drug substance. Pharmaceutical and biotechnology companies opt to outsource their services to contract research organizations (CROs) to save money and time, which is expected to boost the market's growth.

The advancement of medical education and the increase in the number of orphan therapies that are used for the treatment of rare disorders is the primary factor boosting the market growth.

Medical affairs outsourcing assists in the launch of new and innovative products as well as the identification of existing drug indications. As a result, pharmaceutical, biotechnology, and medical device companies use it to effectively perform pre-production, post-production, and clinical trials of medical products.

Medical Affairs Outsourcing Market Report Scope:

Report Coverage Details
Market Size in 2022 USD 1.70 Billion
Projected Forecast Value in 2030 USD 4.28 Billion
Growth Rate 12.2% from 2022 to 2030
Largest Market North America
Base Year 2022
Forecast Period 2022 to 2030
Segments Covered By Services and By Industry
Regions Covered North America, Europe, Asia-Pacific, Latin America and Middle East & Africa

Report Highlights:

  • By Services, The medical writing & publishing segment is expected to expand at a robust growth rate during the forecast period. Medical writing includes the creation of an extensive range of scientific documents, such as published articles, regulatory and research documents, news articles, drug- or disease-related promotional and instructional literature, and content for healthcare websites. In addition, pharmaceutical and biotechnology companies have created a significant demand for regulatory paperwork is one of the key factors boosting the market growth.
  • By Industry, in 2022, the pharmaceutical accounted for the larger revenue share of more than 52%. This increase can be attributed to the increasing demand for medical affairs services for the formation of a draft of new patents due to the expiration of various current patents. Pharmaceutical companies are outsourcing services for better management of product lifecycles and other business operations.

Regional Insights:

North America registered the largest revenue share of more than 30% in 2022, due to the presence of prominent market players, the requirement of expertise for medical affairs, and the cost benefits associated with medical affairs outsourcing are projected to fuel the market growth during the forecast period in the region. The unavailability of medical affairs expertise is a key challenge, which has encouraged pharmaceutical and medical device companies in North America to outsource specific activities to persons with a high level of competence in the domain.

Due to the increasing incidence of diseases, the number of clinical trials is anticipated to increase in the coming years. Pharmaceutical companies in the United States invest more capital, time, and effort in R&D activities. For instance, In the fiscal year 2020, clinical research funding by the National Institutes of Health (NIH) was nearly 17.6 billion U.S. dollars.

On the other hand, the Asia Pacific market is expected to register a rapid CAGR during the forecast period due to the region's CROs' cost-effective service offerings, the region's increasing number of clinical trials, and the growing number of biopharmaceutical companies venturing into the region.

Market Dynamics:


Technological advancement

There is an exponential rise in technological advancement and healthcare investment which helps to encourage the market growth of medical affairs outsourcing in the coming years. Due to the scarcity of medical affairs expertise, several biopharmaceutical and medical device firms have outsourced some tasks to professionals with significant expertise in the domain.

Rising prevalence of both non-communicable and communicable disorders

The rapid growth in the number of non-communicable and communicable disorders is spurring the demand for innovative pharmaceutical and medical equipment and, as a result, increasing demand for medical affairs outsourcing services on a broader scale.


High investment in clinical trials and drug development

The increasing expense of clinical trials and drug development is projected to hamper the growth of the market. It is likely to limit the expansion of the global medical affairs outsourcing market during the forecast period.


Reduced access to healthcare professionals & institutions

The number of visits of Medical Scientific Liaisons (MSLs) to healthcare professionals (HCPs) and institutions has reduced to a certain extent. Face-to-face communication, including the interchange of scientific information and the collection of insights, are two of the core duties of Medical Scientific Liaisons (MSLs) that are adversely impacted as a result of COVID-19. Medical Scientific Liaisons (MSLs) teams have also advanced to one-on-one virtual interactions with professionals and important opinion leaders. This innovative method of communication has largely been adopted by healthcare professionals, who find it helpful and appropriate.

Rapid advancement in research and development

Numerous countries are gradually increasing their R&D spending, which has prompted the expansion of innovative products in the market. Due to the several large and small pharmaceutical and biotechnology firms in addition to the strong healthcare industry. In the coming years, increased research and development across the globe for vaccines, innovative medications, and medical devices is likely to encourage market expansion.

Recent Developments: 

  • In February 2021, ICON plc announced its acquisition of PRA Health Sciences as part of a focus on high-quality and innovative clinical trials in a cash and stock transaction value of nearly USD 12 billion, Services provided by the acquisition will strengthen geographic reach, wider expertise in healthcare technology innovation, and, a deeper understanding of drug therapies and. PRA Health Sciences brings to ICON both mobile and connected health platforms with real-world data and information solutions.
  • In December 2022, As part of the company's commitment to bringing clinical trials nearer to the patient, Syneos Health announced the extension of its strategic agreement with Medable, the industry-leading technology platform for patient-centered clinical trials. Syneos Health and Medable will keep reducing site and patient load, increase enrollment and retention and broaden patient access and diversity through novel decentralized clinical trial (DCT) solutions.
  • In November 2019, Soterius introduced virtual means of Medical Science Liaisons (MSLs) to facilitate the interchange of information which has been proven to be an effective way to reach a large audience.

Major Key Players:

  • ICON plc
  • Wuxi Clinical Development, Inc
  • Pharmaceutical Product Development, LLC
  • Ashfield Healthcare Communications
  • Indegene Inc.
  • IQVIA Holdings Inc
  • The Medical Affairs Company (TMAC)
  • SGS SA
  • Syneos Health Inc
  • ZEINCRO Group

Market Segmentation:

By Services

  • Medical Monitoring
  • Medical Writing & Publishing
  • Medical Information
  • Medical Science Liaisons
  • Others

By Industry

  • Medical Devices
  • Pharmaceutical
  • Biopharmaceutical

Buy this Research Report@

You can place an order or ask any questions, please feel free to contact at| +1 9197 992 333